𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck

✍ Scribed by Mamoru Tsukuda; Yasukazu Mikami; Yuji Tanigaki; Hideaki Katori; Choichi Horiuchi; Yoichi Ikeda; Takahide Taguchi; Machiko Ono; Takahumi Yoshida; Yasunori Sakuma; Ken Aikoh


Publisher
Springer
Year
2004
Tongue
English
Weight
234 KB
Volume
9
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Docetaxel, cisplatin, and 5-fluorouracil
✍ Robert Haddad; A. Dimitrios Colevas; Roy Tishler; Paul Busse; Laura Goguen; Chri πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The authors conducted a series of four Phase I–II trials of high‐dose and intermediate‐dose docetaxel, cisplatin, and 5‐fluorouracil (TPF)‐based induction chemotherapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). The chemotherapy regime

Cisplatin-5-fluorouracil chemotherapy fo
✍ Johnson, Jonas T. ;Mayernik, David G. ;Myers, Eugene N. ;Nolan, Teresa A. ;Schra πŸ“‚ Article πŸ“… 1987 πŸ› Wiley (John Wiley & Sons) βš– 368 KB πŸ‘ 2 views

Patients with locally advanced, inoperable squamous cell carcinoma of the head and neck were offered three courses of cisplatin and 96-h 5-fluorouracil (5-FU) infusion. Subsequent therapy included surgery when feasible, irradiation therapy, and a maintenance program of methotrexate (MTX)-5-FU. Thirt

Pilot study of intraoperative chemothera
✍ Ozlem E. Tulunay; Ileana I. Enamorado; Omer Kucuk; Lance K. Heilbrun; Jose E. Ot πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 3 views

## Abstract ## Background. Intraoperative manipulation of the tumor during cancer surgery has long been recognized as a source of metastasis and contamination of the surgical wound during tumor removal. We explored the use of intraoperative chemotherapy to minimize the risk of tumor cell implantat

Paclitaxel, cisplatin, and 5-fluorouraci
✍ Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 3 views

## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi